FTC Requires Ascension to Divest Surgery Centers as Part of $3.9B AmSurg Acquisition
The Federal Trade Commission (FTC) has mandated that Ascension divest seven surgery centers in specific markets to address antitrust concerns regarding its $3.9 billion acquisition of ambulatory surgery provider AmSurg. The proposed consent order aims to preserve competition for outpatient surgical services, with the deal expected to close soon after compliance.
